Dallas' Enhabit Home Health & Hospice To Be Acquired for $1.1B by Kinderhook Industries

The acquisition is expected to close in the second quarter of 2026, subject to regulatory approvals and other customary closing conditions.

Published on Feb. 24, 2026

Got story updates? Submit your updates here. ›

Enhabit Home Health and Hospice, a Dallas-based national home health and hospice provider, has agreed to be acquired by Kinderhook Industries, a New York City middle market private equity firm, in an all-cash transaction valued at around $1.1 billion. The acquisition was unanimously approved by Enhabit's board and is expected to close in the second quarter of 2026, subject to the receipt of approval of Enhabit stockholders and regulatory approvals, and the satisfaction of other customary closing conditions.

Why it matters

The acquisition of Enhabit, which operates 249 home health locations and 117 hospice locations in 34 states, by Kinderhook Industries will allow the company to benefit from additional resources and expertise to support long-term investments in its people, clinical excellence, and innovation without the short-term pressures of the public markets.

The details

Under the terms of the agreement, Enhabit stockholders will receive $13.80 per share in cash, which represents a premium of approximately 24.4% to the company's closing stock price on February 20, 2026, the last full trading day prior to the announcement of the transaction, and a 33.8% premium to the company's 60-day volume-weighted average share price for the period ending February 20. Upon completion of the transaction, Enhabit will become a private company, no longer listing its common stock on the New York Stock Exchange.

  • The acquisition is expected to close in the second quarter of 2026.
  • Enhabit Home Health and Hospice spun out of its parent company, Encompass Health Corp., and began trading on the New York Stock Exchange in 2022 after reaching more than $1 billion in net revenue the year before.

The players

Enhabit Home Health & Hospice

A Dallas-based national home health and hospice provider with 249 home health locations and 117 hospice locations in 34 states.

Kinderhook Industries

A New York City middle market private equity firm that has agreed to acquire Enhabit Home Health & Hospice in an all-cash transaction valued at around $1.1 billion.

Jeffrey W. Bolton

Chairman of Enhabit's board of directors.

Barb Jacobsmeyer

President and CEO of Enhabit Home Health and Hospice.

Chris Michalik

Managing director at Kinderhook.

Got photos? Submit your photos here. ›

What they’re saying

“Following a thorough evaluation and extensive deliberations in consultation with our independent advisors, we're pleased to reach this agreement with Kinderhook. The board evaluated the current state of the business, its outlook and opportunities, and is confident this transaction maximizes value for our stockholders and is in their best interest.”

— Jeffrey W. Bolton, Chairman of Enhabit's board of directors (Dallas Innovates)

“Over the last four years, Enhabit has strengthened its role as a leading national provider of home health and hospice care, and this agreement is a terrific outcome for our stockholders, clinicians, caregivers, patients and their families. Under Kinderhook's ownership, Enhabit will benefit from additional resources and expertise that will support long-term investments in our people, clinical excellence and innovation without the short-term pressures of the public markets.”

— Barb Jacobsmeyer, President and CEO of Enhabit (Dallas Innovates)

“We have long admired Enhabit's leadership, patient-centric culture and strong market position in home-based care. Kinderhook has a successful 20-year track record of investing in industry-leading companies and partnering with world-class management teams.”

— Chris Michalik, Managing director at Kinderhook (Dallas Innovates)

What’s next

The acquisition is expected to close in the second quarter of 2026, subject to the receipt of approval of Enhabit stockholders and regulatory approvals, and the satisfaction of other customary closing conditions.

The takeaway

The acquisition of Enhabit Home Health & Hospice by Kinderhook Industries will allow the company to continue its mission of delivering exceptional patient care while benefiting from additional resources and expertise to support long-term investments in its people, clinical excellence, and innovation.